Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Carbidopa-Levodopa Treatment Report
What is Carbidopa-Levodopa?

Levodopa is a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 33%
None
2 67%

Most commonly reported side effects

Vivid dreams
1 100%
Drowsiness
1 100%
Dizziness
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  25 mg-100 mg daily 2 x 25 mg-100 mg daily 300 mg daily 3 x 25 mg-100 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Carbidopa-Levodopa (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%
Doctor's advice
1 100% Doctor's advice: 100%

See all 1 patient who’ve stopped taking Carbidopa-Levodopa

Duration See details about how long patients take this treatment ▼

Currently Taking Carbidopa-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Carbidopa-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 33%
Usually
1 33%
Sometimes
0 0%
Never
1 33%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 33%
Not at all
2 67%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
3 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 11, 2010.